Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
After-hours: Aug 15, 2025, 07:52 PM EDT

Assembly Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
23.62M 32.15M 28.52M 28.33M 21.48M 12.95M 7.16M n/a n/a n/a n/a n/a 6.25M 6.25M 6.25M 7.29M 35.65M 75.02M
Cost of Revenue
64K 96K 128K 148K 264K 358K 450K 490K 508K 502K 498K 494K 18.83M 18.83M 18.82M 46.72M 55.19M 78.4M
Gross Profit
23.59M 32.09M 28.42M 28.18M 21.22M 12.59M 6.71M -490K -508K -502K -498K -494K -12.58M -12.58M -12.57M -39.43M -19.54M -3.37M
Operating Income
-43.52M -44.63M -45.42M -46.44M -50.53M -55.82M -64.65M -75.07M -83.43M -90.51M -94.11M -134.03M -129.5M -128.59M -132.69M -109.44M -94.58M -64.34M
Interest Income
3.59M 5.04M 5.57M 6.07M 5.36M 4.49M 3.45M 2.41M 2.04M 1.56M 1.02M 540K 356K 315K 302K 425K 1.02M 1.64M
Pretax Income
-39.04M -39.59M -39.85M -40.37M -45.17M -51.32M -61.2M -72.66M -81.39M -88.95M -93.09M -133.49M -129.14M -128.28M -132.39M -109.02M -93.56M -62.7M
Net Income
-38.96M -39.92M -40.18M -40.8M -45.61M -51.35M -60.62M -71.29M -79.75M -87.21M -91.89M -130.51M -126.43M -125.67M -129.85M -109.02M -93.56M -62.7M
Selling & General & Admin
18M 17.85M 17.94M 21.96M 21.9M 22.42M 22.82M 20.33M 21.37M 23.19M 24.13M 24.51M 25.9M 26.03M 28.78M 29.45M 34.48M 37.03M
Research & Development
58.77M 58.91M 55.93M 52.66M 49.97M 46.23M 48.9M 54.75M 62.05M 67.32M 69.98M 67.87M 68.22M 67.17M 68.52M 87.29M 95.75M 102.33M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
76.77M 76.75M 73.88M 74.62M 71.86M 68.65M 71.72M 75.07M 83.43M 90.51M 94.11M 92.39M 94.11M 93.21M 97.3M 116.73M 130.23M 139.36M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -32K -64K -148K -148K -116K -84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
56.18M 76.91M 74.07M 74.77M 72.01M 68.76M 71.81M 75.07M 83.43M 90.51M 94.11M 92.39M 94.11M 93.21M 97.3M 116.73M 130.23M 139.36M
Income Tax Expense
-76K 330K 318.72K 427.72K 311.72K -90.36K -688.09K -1.49M -1.63M -1.74M -1.21M -2.97M -2.71M -2.6M -2.53M n/a n/a n/a
Shares Outstanding (Basic)
7.66M 7.51M 6.58M 6.35M 5.64M 5.48M 5.48M 4.38M 4.36M 4.25M 4.07M 48.45M 48.29M 48.12M 44.95M 45.57M 42.88M 39.68M
Shares Outstanding (Diluted)
7.66M 7.51M 6.58M 6.35M 5.64M 5.48M 5.48M 4.38M 4.36M 4.25M 4.07M 48.45M 48.29M 48.12M 45.57M 45.57M 42.88M 39.68M
EPS (Basic)
-5.73 -6.38 -6.87 -7.15 -8.93 -10.83 -13.48 -16.8 -13.98 -10.6 -6.77 -2.79 -2.73 -2.78 -2.99 -2.64 -2.32 -1.56
EPS (Diluted)
-5.73 -6.38 -6.87 -7.15 -8.93 -10.83 -13.48 -16.8 -13.98 -10.6 -6.77 -2.77 -2.71 -2.76 -2.97 -2.64 -2.32 -1.58
EBITDA
-43.42M -44.5M -45.29M -46.26M -50.27M -55.46M -64.2M -74.58M -83.05M -90.03M -93.64M -89.16M -84.52M -83.72M -87.83M -108.56M -93.68M -63.43M
EBIT
-42.63M -44.63M -45.42M -46.44M -50.53M -55.82M -64.65M -74.49M -82.84M -89.82M -93.42M -92.28M -87.75M -86.95M -91.05M -109.22M -94.36M -63.42M
Depreciation & Amortization
98K 130K 129K 181K 264K 358K 450K 490K 508K 502K 498K 494K 479K 479K 466K 660K 681K 683K